Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994.
On the basis of several, partially divergent definitions, myocarditis-unlike the often aetiologically unexplained (idiopathic) cardiomyopathies (dilated, hypertrophic, restrictive)-can be classified as c specific disease of the myocardium. This disease often has a known cause and can be due to a large variety of aetiological agents (viral, autoreactive, toxic, infectious processes, etc.) (1). A question still to be answered is whether there is a connection between dilated cardiomyopathy and myocarditis, i.e. whether (virus-induced) myocarditis can progress via a subacute or chronic stage to dilated cardiomyopathy. This question is of considerable diagnostic and therapeutic relevance. The following consensus report thus deals with the clinically important problems related to the diagnosis of myocarditis and dilated cardiomyopathy, examines the aetiological role of immunological mechanisms and discusses the treatment of the two diseases and prognostic factors.
Strauer
B E
BE
Medical Clinic and Policlinic B, University of Düsseldorf, Germany.
Kandolf
R
R
Mall
G
G
Maisch
B
B
Mertens
T
T
Schwartzkopff
B
B
Schultheiss
H P
HP
D002311:Cardiomyopathy, Dilated / Q000209:etiology* / Q000628:therapy / Q000821:virology; D006801:Humans; D009205:Myocarditis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy / Q000821:virology; D014777:Virus Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy